JUN 18, 2021 6:51 AM PDT

Cancer cell lines are too dissimilar from human cancer cells

A new study finds cultured cancer cells lack genetic similarity to humans. This is concerning because cancer cell lines are often used in drug development efforts. The Johns Hopkins Medicine researchers say that their findings should signal a shift in focus in cancer treatment development from cell lines to genetically engineered mice and tumoroids. They report their results, which describe a computer modeling technique that compares RNA sequences among cancer genomes, in the journal Genome Medicine.

"It may not be a surprise to scientists that cancer cell lines are genetically inferior to other models, but we were surprised that genetically engineered mice and tumoroids performed so very well by comparison," noted lead investigator of the study Patrick Cahan, Ph.D. The differences between a human cell's natural environment and a laboratory growth environment explain the dissimilar genetics of cancer cell lines and human cancer cells. "Once you take tumors out of their natural environment, cell lines start to change," explains Cahan, who is an associate professor of biomedical engineering at The Johns Hopkins University and the Johns Hopkins University School of Medicine.

These conclusions were a result of the new modeling technique called CancerCellNet developed by the research team. With CancerCellNet, the team compared the genetic makeup of RNA sequences with data from a cancer genome atlas and found that genetically engineered mice and tumoroids have RNA sequences most similar to cancer cells. They found this to be true in 4 out of every 5 tumor types they tested, which included breast, lung, and ovarian cancers.

CancerCellNet uses RNA to analyze genetic similarities for multiple reasons. "RNA is a pretty good surrogate for cell type and cell identity, which are key to determining whether lab-developed cells resemble their human counterparts," comments Cahan. "RNA expression data is very standardized and available to researchers, and less subject to technical variation that can confound a study's results. 

The researchers have submitted a patent for CancerCellNet and extend the hope that their findings will help inform current and future cancer research models. They continue to work on making CancerCellNet more reliable and precise. 

Sources: Genome Medicine, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
APR 11, 2021
Genetics & Genomics
Trial Shows Personalized Cancer Vaccines are Safe
APR 11, 2021
Trial Shows Personalized Cancer Vaccines are Safe
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin ...
MAY 28, 2021
Genetics & Genomics
Some Biofilms Seem to Activate Cancer Genes
MAY 28, 2021
Some Biofilms Seem to Activate Cancer Genes
New research assessed bacterial and fungal biofilms, tenacious microbial communities that are tougher than small groups ...
JUN 01, 2021
Cancer
No level of secondhand smoke is safe for pregnant women
JUN 01, 2021
No level of secondhand smoke is safe for pregnant women
A study published recently in Environmental Health Perspectives concludes that no amount of exposure to secondhand smoke ...
JUN 16, 2021
Cell & Molecular Biology
A Potential Way to Prevent Metastatic Cancer
JUN 16, 2021
A Potential Way to Prevent Metastatic Cancer
Metastatic cancer is the deadliest, and it can happen years after cancer has been treated to the point of remission. Met ...
JUN 22, 2021
Cancer
Evaluating adverse effects of induction therapy for neuroblastoma
JUN 22, 2021
Evaluating adverse effects of induction therapy for neuroblastoma
A study published in the Journal of Clinical Oncology reports an evaluation of the chemotherapy treatment given to child ...
Loading Comments...